0000922907-14-000240.txt : 20140514 0000922907-14-000240.hdr.sgml : 20140514 20140514145019 ACCESSION NUMBER: 0000922907-14-000240 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20140514 DATE AS OF CHANGE: 20140514 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: China Cord Blood Corp CENTRAL INDEX KEY: 0001467808 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-84917 FILM NUMBER: 14840906 BUSINESS ADDRESS: STREET 1: 48 FL., BANK OF CHINA TOWER STREET 2: 1 GARDEN ROAD CITY: CENTRAL HONG KONG STATE: K3 ZIP: 000000 BUSINESS PHONE: 852-3605-8180 MAIL ADDRESS: STREET 1: 48 FL., BANK OF CHINA TOWER STREET 2: 1 GARDEN ROAD CITY: CENTRAL HONG KONG STATE: K3 ZIP: 000000 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: JAYHAWK CAPITAL MANAGEMENT, L.L.C. CENTRAL INDEX KEY: 0001002078 IRS NUMBER: 481172612 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 8201 MISSION RD STREET 2: SUITE 110 CITY: PRAIRIE VILLAGE STATE: KS ZIP: 66208 BUSINESS PHONE: 9136422611 MAIL ADDRESS: STREET 1: 8201 MISSION RD STREET 2: SUITE 110 CITY: PRAIRIE VILLAGE STATE: KS ZIP: 66208 FORMER COMPANY: FORMER CONFORMED NAME: JAYHAWK CAPITAL MANAGEMENT LLC DATE OF NAME CHANGE: 19961121 SC 13G/A 1 sched13ga_051314.htm sched13ga_051314.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549

SCHEDULE 13G/A
Amendment No. 7

Under the Securities Exchange Act of 1934*


China Cord Blood Corporation
(Name of Issuer)
 
Common Stock, par value $0.0001 per share
(Title of Class of Securities)
 
698659109
(CUSIP Number)
 
December 31, 2013
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

[   ]                 Rule 13d-1(b)
[X]                 Rule 13d-1(c)
[   ]                 Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes).
 
 
 
 

 
 
 

 


CUSIP No.                                 698659109


 
1
 
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON  (entities only)
JCF CO LF, L.P. (45-3936411)
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)  [   ]
(b)  [X]
 
3
 
SEC USE ONLY
 
4
 
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON
WITH:
 
5
 
SOLE VOTING POWER
0
 
6
 
SHARED VOTING POWER
1,858,291
 
7
 
SOLE DISPOSITIVE POWER
0
 
8
 
SHARED DISPOSITIVE POWER
1,858,291
 
9
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,858,291 (see Item 4)
 
10
 
CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES (See Instructions)  [   ]
Not Applicable
 
11
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
2.55%*
 
12
 
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
* Percent of class is based on 73,003,248 outstanding shares of common stock, par value $0.0001 per share, as reported by China Cord Blood Corporation on its Form 6-K/A filed on February 24, 2014.
Explanatory Note: Due to an inadvertent error, shares held by JHAB Fund II, LLC were omitted from Amendment No. 6 to Schedule 13G filed by the reporting person on February 11, 2014.  This Amendment No. 7 to Schedule 13G is filed for the purpose of correcting the error and reflects the reporting person’s ownership as of the date of this filing.




 
 
 
 

 

CUSIP No.                                698659109


 
1
 
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON  (entities only)
Jayhawk Capital Management, L.L.C. (48-1172612)
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)  [   ]
(b)  [X]
 
3
 
SEC USE ONLY
 
4
 
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON
WITH:
 
5
 
SOLE VOTING POWER
0
 
6
 
SHARED VOTING POWER
1,858,291*
 
7
 
SOLE DISPOSITIVE POWER
0
 
8
 
SHARED DISPOSITIVE POWER
1,858,291*
 
9
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,858,291* (see Item 4)
 
10
 
CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES (See Instructions)  [   ]
Not Applicable
 
11
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
2.55%**
 
12
 
OO
* Includes 1,858,291 shares of common stock, par value $0.0001 per share, held by JCF CO LF, L.P.
** Percent of class is based on 73,003,248 outstanding shares of common stock, par value $0.0001 per share, as reported by China Cord Blood Corporation on its Form 6-K/A filed on February 24, 2014.
Explanatory Note: Due to an inadvertent error, shares held by JHAB Fund II, LLC were omitted from Amendment No. 6 to Schedule 13G filed by the reporting person on February 11, 2014.  This Amendment No. 7 to Schedule 13G is filed for the purpose of correcting the error and reflects the reporting person’s ownership as of the date of this filing.




 
 
 
 

 

CUSIP No.                                698659109


 
1
 
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON  (entities only)
Jayhawk Private Equity Fund II, L.P. (26-1692972)
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)  [   ]
(b)  [X]
 
3
 
SEC USE ONLY
 
4
 
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON
WITH:
 
5
 
SOLE VOTING POWER
0
 
6
 
SHARED VOTING POWER
6,340,295
 
7
 
SOLE DISPOSITIVE POWER
0
 
8
 
SHARED DISPOSITIVE POWER
6,340,295
 
9
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
6,340,295 (see Item 4)
 
10
 
CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES (See Instructions)  [   ]
Not Applicable
 
11
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
8.68%*
 
12
 
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
* Percent of class is based on 73,003,248 outstanding shares of common stock, par value $0.0001 per share, as reported by China Cord Blood Corporation on its Form 6-K/A filed on February 24, 2014.
Explanatory Note: Due to an inadvertent error, shares held by JHAB Fund II, LLC were omitted from Amendment No. 6 to Schedule 13G filed by the reporting person on February 11, 2014.  This Amendment No. 7 to Schedule 13G is filed for the purpose of correcting the error and reflects the reporting person’s ownership as of the date of this filing.





 
 
 
 

 

CUSIP No.                                698659109


 
1
 
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON  (entities only)
Jayhawk Private Equity GP II, L.P. (26-1692915)
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)  [   ]
(b)  [X]
 
3
 
SEC USE ONLY
 
4
 
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON
WITH:
 
5
 
SOLE VOTING POWER
0
 
6
 
SHARED VOTING POWER
6,340,295*
 
7
 
SOLE DISPOSITIVE POWER
0
 
8
 
SHARED DISPOSITIVE POWER
6,340,295*
 
9
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
6,340,295* (see Item 4)
 
10
 
CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES (See Instructions)  [   ]
Not Applicable
 
11
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
8.68%**
 
12
 
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
* Includes 6,340,295 shares of common stock, par value $0.0001 per share, held by Jayhawk Private Equity Fund II, L.P.
**Percent of class is based on 73,003,248 outstanding shares of common stock, par value $0.0001 per share, as reported by China Cord Blood Corporation on its Form 6-K/A filed on February 24, 2014.
Explanatory Note: Due to an inadvertent error, shares held by JHAB Fund II, LLC were omitted from Amendment No. 6 to Schedule 13G filed by the reporting person on February 11, 2014.  This Amendment No. 7 to Schedule 13G is filed for the purpose of correcting the error and reflects the reporting person’s ownership as of the date of this filing.



 
 
 
 

 


CUSIP No.                                698659109


 
1
 
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON  (entities only)
Jayhawk Private Equity, LLC (26-1692786)
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)  [   ]
(b)  [X]
 
3
 
SEC USE ONLY
 
4
 
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON
WITH:
 
5
 
SOLE VOTING POWER
0
 
6
 
SHARED VOTING POWER
6,340,295*
 
7
 
SOLE DISPOSITIVE POWER
0
 
8
 
SHARED DISPOSITIVE POWER
6,340,295*
 
9
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
6,340,295* (see Item 4)
 
10
 
CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES (See Instructions)  [   ]
Not Applicable
 
11
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
8.68%**
 
12
 
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
OO
*Includes 6,340,295 shares of common stock, par value $0.0001 per share, held by Jayhawk Private Equity Fund II, L.P.
**Percent of class is based on 73,003,248 outstanding shares of common stock, par value $0.0001 per share, as reported by China Cord Blood Corporation on its Form 6-K/A filed on February 24, 2014.
Explanatory Note: Due to an inadvertent error, shares held by JHAB Fund II, LLC were omitted from Amendment No. 6 to Schedule 13G filed by the reporting person on February 11, 2014.  This Amendment No. 7 to Schedule 13G is filed for the purpose of correcting the error and reflects the reporting person’s ownership as of the date of this filing.

 
 
 
 

 

CUSIP No.                                698659109


 
1
 
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON  (entities only)
JHAB Fund II, LLC (26-1692786)
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)  [   ]
(b)  [X]
 
3
 
SEC USE ONLY
 
4
 
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON
WITH:
 
5
 
SOLE VOTING POWER
0
 
6
 
SHARED VOTING POWER
1,308,901
 
7
 
SOLE DISPOSITIVE POWER
0
 
8
 
SHARED DISPOSITIVE POWER
1,308,901
 
9
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,308,901 (see Item 4)
 
10
 
CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES (See Instructions)  [   ]
Not Applicable
 
11
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
1.79%*
 
12
 
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
OO
*Percent of class is based on 73,003,248 outstanding shares of common stock, par value $0.0001 per share, as reported by China Cord Blood Corporation on its Form 6-K/A filed on February 24, 2014.
Explanatory Note: Due to an inadvertent error, shares held by JHAB Fund II, LLC were omitted from Amendment No. 6 to Schedule 13G filed by the reporting person on February 11, 2014.  This Amendment No. 7 to Schedule 13G is filed for the purpose of correcting the error and reflects the reporting person’s ownership as of the date of this filing.

 
 
 
 

 

CUSIP No.                                698659109


 
1
 
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON  (entities only)
JHAB Management II, LLC
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)  [   ]
(b)  [X]
 
3
 
SEC USE ONLY
 
4
 
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON
WITH:
 
5
 
SOLE VOTING POWER
0
 
6
 
SHARED VOTING POWER
1,308,901*
 
7
 
SOLE DISPOSITIVE POWER
0
 
8
 
SHARED DISPOSITIVE POWER
1,308,901*
 
9
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,308,901*  (see Item 4)
 
10
 
CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES (See Instructions)  [   ]
Not Applicable
 
11
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
1.79%**
 
12
 
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
OO
*Includes 1,308,901 shares of common stock, par value $0.0001 per share, held by JHAB Fund II, LLC.
**Percent of class is based on 73,003,248 outstanding shares of common stock, par value $0.0001 per share, as reported by China Cord Blood Corporation on its Form 6-K/A filed on February 24, 2014.
Explanatory Note: Due to an inadvertent error, shares held by JHAB Fund II, LLC were omitted from Amendment No. 6 to Schedule 13G filed by the reporting person on February 11, 2014.  This Amendment No. 7 to Schedule 13G is filed for the purpose of correcting the error and reflects the reporting person’s ownership as of the date of this filing.


 
 
 
 

 

CUSIP No.                        698659109


 
1
 
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON  (entities only)
Kent C. McCarthy
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)  [   ]
(b)  [X]
 
3
 
SEC USE ONLY
 
4
 
CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON
WITH:
 
5
 
SOLE VOTING POWER
0
 
6
 
SHARED VOTING POWER
9,507,487*
 
7
 
SOLE DISPOSITIVE POWER
0
 
8
 
SHARED DISPOSITIVE POWER
9,507,487*
 
9
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9,507,487* (see Item 4)
 
10
 
CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES (See Instructions)  [   ]
Not Applicable
 
11
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
13.02%**
 
12
 
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
*Includes 1,858,291 shares of common stock, par value $0.0001 per share, held by JCF CO LF, L.P., 6,340,295 shares of common stock, par value $0.0001 per share, held by Jayhawk Private Equity Fund II, L.P. and 1,308,901 shares of common stock, par value $0.0001 per share, held by JHAB Fund II, LLC.
**Percent of class is based on 73,003,248 outstanding shares of common stock, par value $0.0001 per share, as reported by China Cord Blood Corporation on its Form 6-K/A filed on February 24, 2014.
Explanatory Note: Due to an inadvertent error, shares held by JHAB Fund II, LLC were omitted from Amendment No. 6 to Schedule 13G filed by the reporting person on February 11, 2014.  This Amendment No. 7 to Schedule 13G is filed for the purpose of correcting the error and reflects the reporting person’s ownership as of the date of this filing.




 
 
 
 

 

Item 4
Ownership:

Explanatory Note: Due to an inadvertent error, shares held by JHAB Fund II, LLC were omitted from Amendment No. 6 to Schedule 13G filed by the reporting person on February 11, 2014.  This Amendment No. 7 to Schedule 13G is filed for the purpose of correcting the error and reflects the reporting person’s ownership as of the date of this filing.

The information below is as of April 30, 2014.

(a)  Amount beneficially owned:
1.  JCF CO LF, L.P.: 1,858,291
2.  Jayhawk Capital Management, L.L.C.: 1,858,291*
3.  Jayhawk Private Equity Fund II, L.P.: 6,340,295
4.  Jayhawk Private Equity GP II, L.P.: 6,340,295**
5.  Jayhawk Private Equity, LLC: 6,340,295**
6.  JHAB Fund II, LLC: 1,308,901
7.  JHAB Management II, LLC: 1,308,901***
8.  Kent C. McCarthy: 9,507,487****

(b)  Percent of class:
1.  JCF CO LF, L.P.: 2.55%
2.  Jayhawk Capital Management, L.L.C.: 2.55%
3.  Jayhawk Private Equity Fund II, L.P.: 8.68%
4.  Jayhawk Private Equity GP II, L.P.: 8.68%
5.  Jayhawk Private Equity, LLC: 8.68%
6.  JHAB Fund II, LLC: 1.79%
7.  JHAB Management II, LLC: 1.79%
6.  Kent C. McCarthy: 13.02%

Percent of class is based on 73,003,248 outstanding shares of common stock, par value $0.0001 per share, as reported by China Cord Blood Corporation on its Form 6-K/A filed on February 24, 2014.

(c)  Number of shares as to which the person has:

(i)    Sole power to vote or to direct the vote:
1.  JCF CO LF, L.P.: 0
2.  Jayhawk Capital Management, L.L.C.: 0
3.  Jayhawk Private Equity Fund II, L.P.: 0
4.  Jayhawk Private Equity GP II, L.P.: 0
5.  Jayhawk Private Equity, LLC: 0
6.  JHAB Fund II, LLC: 0
7.  JHAB Management II, LLC: 0
6.  Kent C. McCarthy: 0

(ii)    Shared power to vote or direct the vote:
1.  JCF CO LF, L.P.: 1,858,291
2.  Jayhawk Capital Management, L.L.C.: 1,858,291*
3.  Jayhawk Private Equity Fund II, L.P.: 6,340,295
4.  Jayhawk Private Equity GP II, L.P.: 6,340,295**
5.  Jayhawk Private Equity, LLC: 6,340,295**
6.  JHAB Fund II, LLC: 1,308,901
7.  JHAB Management II, LLC: 1,308,901***
8.  Kent C. McCarthy: 9,507,487****

(iii)   Sole power to dispose or to direct the disposition of:
1.  JCF CO LF, L.P.: 0
2.  Jayhawk Capital Management, L.L.C.: 0
3.  Jayhawk Private Equity Fund II, L.P.: 0
4.  Jayhawk Private Equity GP II, L.P.: 0
5.  Jayhawk Private Equity, LLC: 0
6.  JHAB Fund II, LLC: 0

 
 
 
 

 



 
7.  JHAB Management II, LLC: 0
6.  Kent C. McCarthy: 0
 
 
 (iv)  Shared power to dispose or to direct the disposition of:
1.  JCF CO LF, L.P.: 1,858,291
2.  Jayhawk Capital Management, L.L.C.: 1,858,291*
3.  Jayhawk Private Equity Fund II, L.P.: 6,340,295
4.  Jayhawk Private Equity GP II, L.P.: 6,340,295**
5.  Jayhawk Private Equity, LLC: 6,340,295**
6.  JHAB Fund II, LLC: 1,308,901
7.  JHAB Management II, LLC: 1,308,901***
8.  Kent C. McCarthy: 9,507,487****

*Includes 1,858,291 shares of common stock, par value $0.0001 per share held by JCF CO LF, L.P.
**Includes 6,340,295 shares of common stock, par value $0.0001 per share held by Jayhawk Private Equity Fund II, L.P.
***Includes 1,308,901 shares of common stock, par value $0.0001 per share held by JHAB Fund II, LLC.
****Includes 1,858,291 shares of common stock, par value $0.0001 per share, held by JCF CO LF, L.P., 6,340,295 shares of common stock, par value $0.0001 per share, held by Jayhawk Private Equity Fund II, L.P., and 1,308,901 shares of common stock, par value $0.0001 per share held by JHAB Fund II, LLC.
 
 

Item 10
Certification:

By signing below each party certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
 
 
 
 

 
 
 
 

 

 
 
 
 
SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, the parties below certify that the information set forth in this statement is true, complete and correct.

Dated:
May 14, 2014
 
 
 
 
 
 
 /s/ Kent C. McCarthy
 
 
 
Kent C. McCarthy
 
 
 
 
 

 
Jayhawk Capital Management, L.L.C.
 
 
 
 
 
 
By:
 /s/ Kent C. McCarthy
 
 
 
Name: Kent C. McCarthy
 
 
 
Title: Manager
 
 
 
 
Jayhawk Private Equity, LLC
 
 
 
 
 
 
By:
 /s/ Kent C. McCarthy
 
 
 
Name:  Kent C. McCarthy
 
 
 
Title: Manager
 

 
JHAB Management II, LLC
 
 
 
 
 
 
By:
 /s/ Kent C. McCarthy
 
 
 
Name:  Kent C. McCarthy
 
 
 
Title: Manager
 

 
Jayhawk Private Equity GP II, L.P.
 
 
 
 
 
 
By:
 
 
By:
Jayhawk Private Equity, LLC
Its general partner
 
/s/ Kent C. McCarthy                                                     
 
 
Name: 
Kent C. McCarthy
 
 
Title:
Manager
 

 
Jayhawk Private Equity Fund II, L.P.
 
 
 
 
 
 
By:
 
 
 
 
 
By:
Jayhawk Private Equity GP II, L.P.
Its general partner
 
By: Jayhawk Private Equity, LLC
Its general partner
 
/s/ Kent C. McCarthy                                                     
 
 
Name:
Kent C. McCarthy
 
 
Title:
Manager
 

 
JCF CO LF, L.P.
 
 
 
 
 
 
By:
 
 
By:
Jayhawk Capital Management, L.L.C.
Its General Partner
 
/s/ Kent C. McCarthy                                                    
 
 
Name:
Kent C. McCarthy
 
 
Title:
Manager
 

 
JHAB Fund II, LLC
 
 
 
 
 
 
By:
 
 
By:
 JHAB Management II, LLC
Its Manager
 
/s/ Kent C. McCarthy                                                     
 
 
Name:
Kent C. McCarthy
 
 
Title:
Manager
 


 
 
 
 

 

Exhibit A

 
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13G/A

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G/A (including amendments thereto) with respect to the Common Stock, par value $0.0001 per share, of China Cord Blood Corporation, and further agree that this Agreement be included as an exhibit to such filings.

In evidence whereof, the undersigned have caused this Agreement to be executed on their behalf this 14th day of May, 2014.

 
 
 
 
 
 
 
 
 /s/ Kent C. McCarthy
 
 
 
Kent C. McCarthy
 
 
 
 
 

 
Jayhawk Capital Management, L.L.C.
 
 
 
 
 
 
By:
 /s/ Kent C. McCarthy
 
 
 
Name: Kent C. McCarthy
 
 
 
Title: Manager
 
 
 
 
Jayhawk Private Equity, LLC
 
 
 
 
 
 
By:
 /s/ Kent C. McCarthy
 
 
 
Name:  Kent C. McCarthy
 
 
 
Title: Manager
 

 
JHAB Management II, LLC
 
 
 
 
 
 
By:
 /s/ Kent C. McCarthy
 
 
Name:
Kent C. McCarthy
 
 
Title:
Manager
 

 
Jayhawk Private Equity GP II, L.P.
 
 
 
 
 
 
By:
 
 
By:
Jayhawk Private Equity, LLC
Its general partner
 
 /s/ Kent C. McCarthy                                                    
 
 
Name:
Kent C. McCarthy
 
 
Title:
Manager
 

 
Jayhawk Private Equity Fund II, L.P.
 
 
 
 
 
 
By:
 
 
 
 
 
By:
Jayhawk Private Equity GP II, L.P.
Its general partner
 
By: Jayhawk Private Equity, LLC
Its general partner
 
/s/ Kent C. McCarthy                                                     
 
 
Name:
Kent C. McCarthy
 
 
Title:
Manager
 



 
 
 
 

 


 
 
JCF CO LF, L.P.
 
 
 
 
 
 
By:
 
 
By:
Jayhawk Capital Management, L.L.C.
Its General Partner
 
/s/ Kent C. McCarthy                                                     
 
 
Name:
Kent C. McCarthy
 
 
Title:
Manager
 

 
JHAB Fund II, LLC
 
 
 
 
 
 
By:
 
 
By:
JHAB Management II, LLC
Its Manager
 
/s/ Kent C. McCarthy                                                     
 
 
Name:
Kent C. McCarthy
 
 
Title:
Manager